Detalles de la búsqueda
1.
A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.
Blood
; 137(19): 2646-2656, 2021 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33512419
2.
Impact of central nervous system involvement in adult patients with Philadelphia-negative acute lymphoblastic leukemia: a GRAALL-2005 study.
Haematologica
; 108(12): 3287-3297, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36891751
3.
Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC.
Ann Hematol
; 99(8): 1855-1862, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32564196
4.
A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD.
Blood
; 129(5): 643-649, 2017 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27899357
5.
DNMT3A mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemia.
Haematologica
; 104(8): 1617-1625, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30655366
6.
Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM-TC) multicentre cohort study.
Br J Haematol
; 192(5): e121-e124, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33522598
7.
Decreased nonrelapse mortality after unrelated cord blood transplantation for acute myeloid leukemia using reduced-intensity conditioning: a prospective phase II multicenter trial.
Biol Blood Marrow Transplant
; 21(3): 445-53, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25460357
8.
Concomitant haemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID-19 and acute promyelocytic leukaemia.
Br J Haematol
; 189(6): 1054-1056, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32369614
9.
Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Cancer
; 120(6): 855-63, 2014 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24338939
10.
Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial.
Haematologica
; 99(9): 1486-91, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24951467
11.
Impact of disease status and stem cell source on the results of reduced intensity conditioning transplant for Hodgkin's lymphoma: a retrospective study from the French Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
Haematologica
; 98(9): 1467-75, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23539540
12.
Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TC.
Bone Marrow Transplant
; 58(1): 72-79, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36261707
13.
Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC.
Bone Marrow Transplant
; 58(12): 1331-1338, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37653054
14.
Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS.
Bone Marrow Transplant
; 58(5): 534-543, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36774430
15.
Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trial.
EClinicalMedicine
; 62: 102111, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37654670
16.
Unrelated Cord Blood Transplantation in Children, Adolescents, and Young Adults with Acute Leukemia or Myelodysplastic Syndrome: A Retrospective Comparative Study from the French Society for Bone Marrow Transplantation and Cellular Therapy Between Real-World Data and Previously Reported Results of a Randomized Clinical Trial.
Transplant Cell Ther
; 28(11): 780.e1-780.e7, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36002106
17.
Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Br J Haematol
; 152(3): 331-9, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21133885
18.
Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Biol Blood Marrow Transplant
; 16(1): 78-85, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19744569
19.
Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study.
Haematologica
; 95(10): 1762-8, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20634495
20.
Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström's macroglobulinemia. Results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Haematologica
; 95(6): 950-5, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20081058